Patent details

EP2892900 Title: PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2892900
WO Application Number:
US2013058614
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP13762703.0
WO Publication Number:
WO2014039899
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
06/09/2013
Grant date:
16/08/2017
EP Publication Date:
15/07/2015
WO Publication Date:
13/03/2014
Claims Translations Received Date:
Claims Translation B1 Received Date:
19/10/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
16/08/2017
EP B1 Publication Date:
16/08/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
05/09/2033
Lapsed By Expiration Date:
Patent Validated Date:
02/11/2017
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
16/08/2017
 
 

 

Name:
Principia Biopharma Inc.
Address:
400 East Jamie Court, Suite 302, South San Francisco, CA 94080, United States of America (US)

Domicile Holder

Name:
ir. W.J.J.M. Kempes
From:
19/10/2017
Address:
Dogio Patents Postbus 2350, 1200 CJ, Hilversum, Netherlands (NL)
To:

Inventor

1

Name:
OWENS, Tim
Address:
South San Francisco California 94080, United States of America (US)

2

Name:
VERNER, Erik
Address:
Belmont, CA 94002, United States of America (US)

Priority

1

Priority Patent Number:
201361782605 P
Priority Date:
14/03/2013
Priority Country:
United States of America (US)

2

Priority Patent Number:
201261728693 P
Priority Date:
20/11/2012
Priority Country:
United States of America (US)

3

Priority Patent Number:
201261699038 P
Priority Date:
10/09/2012
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/519; A61P 29/00; A61P 35/00; A61P 37/00; C07D 487/04; C07D 519/00;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
45/17
Publication date:
08/11/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
33/17
Publication date:
18/08/2017
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201733
Publication date:
16/08/2017
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
30/09/2025
Annual Fee Number:
13
Annual Fee Amount:
700 Euro
Last Annual Payment Date:
05/07/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
600 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
01/11/2017 Outgoing Correspondence Letter no formal defects 1 PDF /8/5/4/5/8/0800185458/docs/ep13762703.0_0_171879l271.pdf
19/10/2017 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /8/5/4/5/8/0800185458/docs/ep13762703.0_1_incomingcorrespondenceelectronic20171019183844981.pdf
19/10/2017 Claims First filed claims 8 PDF /8/5/4/5/8/0800185458/docs/ep13762703.0_2_claims20171019183844116.pdf